Chris Hartl, Ph.D. (Epigenome Technologies) || Special Seminar

We are pleased to welcome Chris Hartl, PhD, Chief Technology Officer at Epigenome Technologies for a Special Seminar. Dr. Hartl will present an update on the company’s latest news and innovations and how they can work with you to enhance your research.

Christopher Hartl, Ph.D. is Chief Technology Officer at Epigenome Technologies, where he leads the development of scalable single-cell and spatial epigenomics products. He brings over 15 years of experience building high-performance computational tools and bioinformatics platforms across both academic genomics and commercial biotech. At the Broad Institute, he helped develop foundational methods in variant detection and large-scale genomic analysis. At Rancho Biosciences, he led product development for multi-omic integration, clinical data modeling, and AI-powered target discovery. His work spans algorithm design, machine learning, and cloud-scale analytics, with a focus on turning complex biological data into usable insight. Chris holds a Ph.D. in Bioinformatics from UCLA, where his research combined epigenetics, transcriptomics, and systems biology to study gene regulation in neurodevelopmental disorders.